Advertisement
Accuray Incorporated

Accuray Incorporated Fundamental Analysis

ARAYNASDAQ
HealthcareMedical - Devices
$0.33
$0.02(5.53%)
U.S. Market opens in 5h 0m
Advertisement

Accuray Incorporated Fundamental Analysis

Accuray Incorporated (ARAY) shows weak financial fundamentals with a PE ratio of -0.88, profit margin of -10.76%, and ROE of -77.48%. The company generates $0.4B in annual revenue with weak year-over-year growth of 2.68%.

Key Strengths

Cash Position91.44%
PEG Ratio-0.01

Areas of Concern

ROE-77.48%
Operating Margin-3.53%
We analyze ARAY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -76.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-76.1/100

We analyze ARAY's fundamental strength across five key dimensions:

Efficiency Score

Weak

ARAY struggles to generate sufficient returns from assets.

ROA > 10%
-10.31%

Valuation Score

Excellent

ARAY trades at attractive valuation levels.

PE < 25
-0.88
PEG Ratio < 2
-0.01

Growth Score

Moderate

ARAY shows steady but slowing expansion.

Revenue Growth > 5%
2.68%
EPS Growth > 10%
90.31%

Financial Health Score

Moderate

ARAY shows balanced financial health with some risks.

Debt/Equity < 1
4.37
Current Ratio > 1
1.42

Profitability Score

Weak

ARAY struggles to sustain strong margins.

ROE > 15%
-7747.64%
Net Margin ≥ 15%
-10.76%
Positive Free Cash Flow
No

Key Financial Metrics

Is ARAY Expensive or Cheap?

P/E Ratio

ARAY trades at -0.88 times earnings. This suggests potential undervaluation.

-0.88

PEG Ratio

When adjusting for growth, ARAY's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Accuray Incorporated at 0.97 times its book value. This may indicate undervaluation.

0.97

EV/EBITDA

Enterprise value stands at 16.17 times EBITDA. This signals the market has high growth expectations.

16.17

How Well Does ARAY Make Money?

Net Profit Margin

For every $100 in sales, Accuray Incorporated keeps $-10.76 as profit after all expenses.

-10.76%

Operating Margin

Core operations generate -3.53 in profit for every $100 in revenue, before interest and taxes.

-3.53%

ROE

Management delivers $-77.48 in profit for every $100 of shareholder equity.

-77.48%

ROA

Accuray Incorporated generates $-10.31 in profit for every $100 in assets, demonstrating efficient asset deployment.

-10.31%

Following the Money - Real Cash Generation

Operating Cash Flow

Accuray Incorporated generates limited operating cash flow of $-18.29M, signaling weaker underlying cash strength.

$-18.29M

Free Cash Flow

Accuray Incorporated generates weak or negative free cash flow of $-27.71M, restricting financial flexibility.

$-27.71M

FCF Per Share

Each share generates $-0.23 in free cash annually.

$-0.23

FCF Yield

ARAY converts -73.80% of its market value into free cash.

-73.80%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.88

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.97

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.09

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

4.37

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.42

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.77

vs 25 benchmark

ROA

Return on assets percentage

-0.10

vs 25 benchmark

ROCE

Return on capital employed

-0.06

vs 25 benchmark

How ARAY Stacks Against Its Sector Peers

MetricARAY ValueSector AveragePerformance
P/E Ratio-0.8829.34 Better (Cheaper)
ROE-77.48%688.00% Weak
Net Margin-10.76%-52372.00% (disorted) Weak
Debt/Equity4.370.49 Weak (High Leverage)
Current Ratio1.424.37 Neutral
ROA-10.31%-20476.00% (disorted) Weak

ARAY outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Accuray Incorporated's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

4.71%

Industry Style: Defensive, Growth, Innovation

Growing

EPS CAGR

-136.36%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

270.26%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ